STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns

Scientists utilized an advanced genome-editing tool in early human embryos to investigate the function of a key gene in early development, according to research published in Nature on Thursday. This next-generation CRISPR technology demonstrated enhanced precision and reduced damage compared to earlier versions, suggesting potential future clinical applications for correcting genetic mutations or selecting for traits. The study also indicated that edited embryos can develop to a stage suitable for uterine implantation. However, the researchers noted that the base editing technique did not achieve uniform edits across all cells in the early embryos, resulting in a mosaic of altered and unaltered cells. This finding aligns with similar research reported earlier in the month, highlighting ongoing challenges in achieving consistent gene editing outcomes in embryonic development. The research simultaneously advances basic biological understanding and intensifies ethical discussions surrounding the use of such technologies for reproductive purposes.